By elucidating the intricate interplay between LL37, TLR2, and JAK2/STAT3 signaling in mast cells, our findings provide novel mechanistic insights into rosacea pathogenesis and lay the groundwork for the development of targeted therapies. This evidence concerns the gene TLR2 and rosacea.